Cannara Biotech Value At Risk

LOVFF Stock  USD 1.32  -0.01  -0.75%   
The Value At Risk reading for Cannara Biotech is computed from historical trading observations. Each data point is derived from standardized price and volume feeds. Cannara Biotech has a market cap of 63.27 M, operating margin of 15.05%, ROE of 4.34%. Correlation Analysis adds portfolio-level perspective. A position in Cannara Biotech is indicated here. Position allocation is driven by the portfolio construction model. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Cannara Biotech has current Value At Risk of -3.47. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.

Value At Risk

 = 

ER[a] x N

+

(Z-SCORE x STD x SQRT (N))

 = 
-3.47
ER[a] = Expected return on investing in Cannara Biotech
STD =   Standard Deviation of Cannara Biotech
N = Number of points for the period
Z-SCORE = Number of standard deviations above or below the mean

Value At Risk Peers Comparison

Value At Risk Relative To Other Indicators

Cannara Biotech is rated below average in value at risk across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time. Compare Cannara Biotech to Peers

Other Technical Indicators